Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Market status
Market status
Early Stage Concept
Products 41 to 50 of 69
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Medusoid: Tissue-Engineered Biomimetic Jellyfish
by
Harvard University
+
Caltech
Biotech components:
Animal
Business models:
B2B
Country of production:
USA
Country of distribution:
N/A
Intended consumer:
Research
+
Commercial
Date added:
2018/08/30 11:49 (3 years ago)
Date last modified:
2018/08/30 11:49 (3 years ago)
Known funding amount:
N/A
Funding types:
University
Industry:
Health
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
Medical (Device)
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Methane bioconversion: Farnesene
by
Intrexon
Biotech components:
Bacteria
+
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/13 11:47 (2 years ago)
Date last modified:
2019/09/13 11:47 (2 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Energy
+
Industrial
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Fuel and Energy
+
Chemical
Production process:
N/A
Source:
N/A
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Input
Methane Bioconversion: Isobutanol
by
Intrexon
Biotech components:
Bacteria
+
Gene Editing
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/13 11:47 (2 years ago)
Date last modified:
2019/09/16 16:29 (2 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Energy
+
Industrial
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Fuel and Energy
+
Chemical
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Methane bioconversion: isoprene
by
Intrexon
Biotech components:
Bacteria
+
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/13 11:47 (2 years ago)
Date last modified:
2019/09/13 11:47 (2 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Chemical
+
Other (Industrial)
Production process:
N/A
Source:
N/A
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Input
MG53 (natural human protein) (preventing lethal lung damage from the flu)
by
Ohio State University
Biotech components:
Molecule
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:39 (4 months ago)
Date last modified:
2020/12/18 14:39 (4 months ago)
Known funding amount:
N/A
Funding types:
University
Industry:
Medical
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
Medicine
+
Medical Treatment
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
N/A
Micro-algae fatty acids
by
Flinders University
Biotech components:
Microbe
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:39 (4 months ago)
Date last modified:
2020/12/18 14:39 (4 months ago)
Known funding amount:
N/A
Funding types:
University
Industry:
Food & Agriculture
+
Health
Market status:
Early Stage Concept
Organization type(s):
University
Product categories:
Food
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
N/A
Microbial Fuel Cells
by
Lebônê
Biotech components:
Microbe
Business models:
B2C
Country of production:
South Africa
Country of distribution:
Namibia
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (3 years ago)
Date last modified:
2019/05/15 15:40 (2 years ago)
Known funding amount:
300,000 USD
Funding types:
Development Bank
+
Foundation
Industry:
Industrial
Market status:
Early Stage Concept
+
No longer on the market
Organization type(s):
Private Company
Product categories:
Fuel and Energy
Production process:
Open Release
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Finished Product
NanoHeal
by
RISE PFI AS
Biotech components:
Molecule
Business models:
B2B
Country of production:
Norway
Country of distribution:
Norway
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (3 years ago)
Date last modified:
2018/10/08 14:51 (3 years ago)
Known funding amount:
N/A
Funding types:
Government
+
University
Industry:
Health
Market status:
Early Stage Concept
Organization type(s):
Research Institution
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
Non-browning avocado
by
Intrexon
Biotech components:
Gene Editing
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 14:31 (2 years ago)
Date last modified:
2019/09/12 14:31 (2 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Food
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
Non-browning cherries
by
Intrexon
Biotech components:
Gene Editing
Business models:
B2C
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2019/09/12 15:10 (2 years ago)
Date last modified:
2019/09/12 15:10 (2 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
Early Stage Concept
Organization type(s):
Public Company
Product categories:
Food
Production process:
N/A
Source:
Web search
Trading symbol:
XON
(NASDAQ)
Value chain stage:
Finished Product
1
2
3
4
5
6
7
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
